From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
出版年份 2018 全文链接
标题
From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 24, Issue 33, Pages 3681-3694
出版商
Baishideng Publishing Group Inc.
发表日期
2018-09-06
DOI
10.3748/wjg.v24.i33.3681
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn’s Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis
- (2018) Mathilde Huguet et al. INFLAMMATORY BOWEL DISEASES
- The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
- (2018) Yang Woon Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases
- (2017) Jean-Frederic Colombel et al. GASTROENTEROLOGY
- Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease
- (2017) Anke Heida et al. INFLAMMATORY BOWEL DISEASES
- Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
- (2017) Jean-Frederic Colombel et al. LANCET
- Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohns disease with fecal calprotectin
- (2017) Juan María Vázquez Morón et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China
- (2017) Jin-Min Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
- (2017) Yu Fu et al. Scientific Reports
- Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
- (2017) Saranya Kittanakom et al. Canadian Journal of Gastroenterology and Hepatology
- Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
- (2016) Shailja C. Shah et al. Clinical Gastroenterology and Hepatology
- Fecal calprotectin for the prediction of small-bowel Crohn’s disease by capsule endoscopy
- (2016) Uri Kopylov et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohnʼs Disease
- (2016) Esther Garcia-Planella et al. INFLAMMATORY BOWEL DISEASES
- Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis
- (2016) Klaus Theede et al. INFLAMMATORY BOWEL DISEASES
- Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohnʼs Disease
- (2016) Eran Zittan et al. INFLAMMATORY BOWEL DISEASES
- Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy
- (2016) Rocio Ferreiro-Iglesias et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis
- (2016) Marianne Guirgis et al. Journal of Crohns & Colitis
- The utility of faecal calprotectin to predict post-operative recurrence in Crohńs disease
- (2016) Maria Teresa Herranz Bachiller et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn’s disease: a long-term prospective study
- (2016) Takayuki Yamamoto et al. Therapeutic Advances in Gastroenterology
- Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease
- (2015) S. C. Shah et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Can Fecal Biomarkers Detect Ileal Inflammation in Inflammatory Bowel Disease?
- (2015) Takayuki Yamamoto et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS
- (2015) Stacy B Menees et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn’s Disease
- (2015) Gilles Boschetti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Editorial: Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed?
- (2015) Alain Schoepfer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis
- (2015) Klaus Theede et al. Clinical Gastroenterology and Hepatology
- Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
- (2015) Emily K. Wright et al. GASTROENTEROLOGY
- High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis
- (2015) Margalida Calafat et al. INFLAMMATORY BOWEL DISEASES
- Crohn's disease management after intestinal resection: a randomised trial
- (2015) Peter De Cruz et al. LANCET
- Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
- (2015) Eamonn M. M. Quigley Therapeutic Advances in Gastroenterology
- Fecal Calprotectin Concentrations in Healthy Children Aged 1-18 Months
- (2015) Feng Li et al. PLoS One
- Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission
- (2014) Jordi Guardiola et al. Clinical Gastroenterology and Hepatology
- Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
- (2014) N Waugh et al. HEALTH TECHNOLOGY ASSESSMENT
- Meta-analysis
- (2014) Jin-Feng Lin et al. INFLAMMATORY BOWEL DISEASES
- Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
- (2014) Pauliina Molander et al. Journal of Crohns & Colitis
- The intra-individual variability of faecal calprotectin: A prospective study in patients with active ulcerative colitis
- (2014) Anders Lasson et al. Journal of Crohns & Colitis
- Low Fecal Calprotectin Predicts Sustained Clinical Remission in Inflammatory Bowel Disease Patients: A Plea for Deep Remission
- (2014) Erik Mooiweer et al. Journal of Crohns & Colitis
- Fecal calprotectin one year after ileocaecal resection for Crohn's disease — A comparison with findings at ileocolonoscopy
- (2014) Anders Lasson et al. Journal of Crohns & Colitis
- Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome
- (2014) MING-HUI CHANG et al. Molecular Medicine Reports
- Fecal calprotectin in healthy children
- (2014) Tonje Oord et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders
- (2014) Gian Paolo Caviglia et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration
- (2014) Kousaku Kawashima et al. Biomed Research International
- The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn’s disease
- (2014) Takayuki Yamamoto United European Gastroenterology Journal
- A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease
- (2013) G. D. Naismith et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab Induces Deep Remission in Patients With Crohn's Disease
- (2013) Jean–Frédéric Colombel et al. Clinical Gastroenterology and Hepatology
- Fecal Calprotectin Levels Predict the Clinical Course in Patients With New Onset of Ulcerative Colitis
- (2013) Anders Lasson et al. INFLAMMATORY BOWEL DISEASES
- Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
- (2013) Alain M. Schoepfer et al. INFLAMMATORY BOWEL DISEASES
- Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
- (2013) Martine De Vos et al. INFLAMMATORY BOWEL DISEASES
- Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion
- (2013) Gerhard Rogler et al. Journal of Crohns & Colitis
- A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease
- (2013) Triana Lobatón et al. Journal of Crohns & Colitis
- Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care
- (2013) Polychronis Pavlidis et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: A prospective pilot study
- (2013) Takayuki Yamamoto et al. United European Gastroenterology Journal
- Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method
- (2012) Liselotte Coorevits et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
- (2012) Pauliina Molander et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
- (2012) Ren Mao et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
- (2012) Geert DʼHaens et al. INFLAMMATORY BOWEL DISEASES
- P274 Close monitoring of CRP and fecal calprotectin levels to predict relapse in Crohn's disease patients. A sub-analysis of the STORI study
- (2012) N. de Suray et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
- (2012) Gert Van Assche et al. Journal of Crohns & Colitis
- Effect of Bowel Cleansing for Colonoscopy on Fecal Calprotectin Levels in Pediatric Patients
- (2012) Kaija-Leena Kolho et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits
- (2012) S. J. Whitehead et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study
- (2011) D. Laharie et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Epidemiology and Natural History of Inflammatory Bowel Diseases
- (2011) Jacques Cosnes et al. GASTROENTEROLOGY
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
- (2011) Judith E. Baars et al. INFLAMMATORY BOWEL DISEASES
- Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers
- (2011) Alain M. Schoepfer et al. Journal of Crohns & Colitis
- Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers
- (2011) Petr Ricanek et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation?
- (2010) John Keohane et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
- (2009) G T Ho et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Natural History of Adult Crohn's Disease in Population-Based Cohorts
- (2009) Laurent Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Elevated Human β-Defensin-2 Levels Indicate an Activation of the Innate Immune System in Patients With Irritable Bowel Syndrome
- (2009) Jost Langhorst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease
- (2009) C. A. Lamb et al. BRITISH JOURNAL OF SURGERY
- Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis
- (2009) Matt W. Johnson et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Ulcerative colitis
- (2009) Alain M. Schoepfer et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis†
- (2009) Mikko P. Pakarinen et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin variability in Crohnʼs disease
- (2009) Bjrn Moum et al. INFLAMMATORY BOWEL DISEASES
- Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease
- (2009) Manohara Joishy et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?
- (2008) Renata D'Incà et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
- (2008) Charlotte M.T. Otten et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
- (2008) R. Berni Canani et al. DIGESTIVE AND LIVER DISEASE
- Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease
- (2008) J.P. Gisbert et al. DIGESTIVE AND LIVER DISEASE
- Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis
- (2008) Jun-Ying Xiang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
- (2008) Michael Wagner et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
- (2007) Alain M. Schoepfer et al. INFLAMMATORY BOWEL DISEASES
- Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings
- (2007) Taina Sipponen et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started